Cover Image
市場調查報告書

全球克隆氏症市場

Global Market Study on Crohn's Disease: Anti-inflammatory Drugs Segment Anticipated to be the Most Lucrative Segment Through 2024

出版商 Persistence Market Research 商品編碼 457204
出版日期 內容資訊 英文 120 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球克隆氏症市場 Global Market Study on Crohn's Disease: Anti-inflammatory Drugs Segment Anticipated to be the Most Lucrative Segment Through 2024
出版日期: 2017年01月11日 內容資訊: 英文 120 Pages
簡介

本報告提供全球克隆氏症市場相關調查,彙整市場趨勢與預測,各藥物類型,各流通管道,各地區趨勢,及打入市場的主要企業簡介等資料。

第1章 摘要整理

第2章 市場概要

  • 簡介
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會
    • 價值鏈
  • 流行病學
  • 階段性治療範例
  • 現在及未來的治療方法

第3章 市場預測

  • 簡介
  • 市場趨勢

第4章 市場分析:各藥物類型

  • 簡介
  • 市場規模預測和絕對值及機會
    • 抗發炎性藥
    • 免疫系抑制劑
    • 抗生素
    • 生技藥品
    • 抗腹瀉劑
    • 止痛藥
  • 魅力度分析

第5章 市場分析:各流通管道

  • 簡介
  • 市場規模預測和絕對值及機會
    • 醫院
    • 零售藥局
    • 線上藥局
    • 藥妝店
  • 魅力度分析

第6章 市場分析:各地區

  • 簡介
  • 市場規模預測和絕對值及機會
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 魅力度分析

第7章 北美市場

第8章 南美市場

第9章 歐洲市場

第10章 亞太地區市場

第11章 中東·非洲市場

第12章 競爭環境

  • 競爭儀表板
  • 企業簡介
  • 全球參與企業

第13章 預測和簡稱

第14章 調查方法

目錄

In its recently published report titled "Crohn's Disease Market: Global Industry Analysis and Forecast, 2016-2024," Persistence Market Research presents an outlook of the global Crohn's disease market for the projected period of eight years. The primary objective of the report is to offer insights into developments in the global Crohn's disease market that are affecting global businesses and enterprises. The report provides updates on market opportunities and insights to understand the growth and performance of the key segments of the global Crohn's disease market. Through extensive research, Persistence Market Research analysts have studied how the different market dynamics are likely to impact the current and future scenario of the global Crohn's disease market, thereby providing useful insights to market players to plan their future business strategies. The report covers the global Crohn's disease market performance in terms of revenue contribution from various segments. This report also includes Persistence Market Research's exclusive analysis of key trends, drivers, restraints and opportunities, which are influencing the growth of the global Crohn's disease market. Impact analysis of key growth drivers and restraints are included in this report to better equip clients with crystal clear decision-making insights.

The report on the global Crohn's disease market begins with an overview of Crohn's disease, types of drugs used for treatment and key market definitions. The analysts also present an executive summary along with market taxonomy where the global Crohn's disease market is segmented on the basis of drug type, distribution channel and region. The analysts also offer an unbiased analysis of overall market approach, target geographies and different strategies adopted by the key players across the globe to strengthen their market position in the next few years. Another section of the report consists of Crohn's disease epidemiology, treatment paradigms and medications for the disease. The value chain of the market included in this report adds focus towards enhancing patient safety and product innovation that are key features expected to emerge in the global Crohn's disease market.

The report concludes with a study of the market performance of some of the top companies operating in the global Crohn's disease market. Persistence Market Research analysts have profiled some of the leading market players and presented a detailed analysis of their overall business performance and a comprehensive evaluation of their short-term and long-term business and go-to-market strategies. This section is intended to provide report audiences with a dashboard view of the competitive landscape of the global Crohn's disease market.

Market segmentation

By Drug Type

  • Anti-inflammatory drugs
  • Immune system suppressors
  • Antibiotics
  • Biologics
  • Anti-diarrheal
  • Pain relievers

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • MEA

Exclusive research methodology

Yearly change in inflation rate has not been factored in while forecasting market numbers. While researching this report indicators such as R&D expenditure, research funding from government and non-profit organizations etc. have been considered to arrive at the indicated market numbers. A bottom-up approach has been used to evaluate market numbers for each product category, while top-down approach has been used to counter-validate the reached numbers. The analysts have done in-depth secondary research to ascertain overall market size, top industry players, and top products. In order to conduct expert and industry interviews, Persistence Market Research has formulated a detailed discussion guide, post which the analysts have conducted interviews with industry experts, industry players, retailers and distributors.

Market examination on Year-on-Year growth parameter

It is imperative to note that in an ever-fluctuating global economy, the report not only conducts forecasts in terms of CAGR but also analyzes the market on the basis of key parameters such as Year-on-Year (Y-o-Y) growth to understand the predictability of the market and to identify the right opportunities in the global Crohn's disease market. Another key feature of this report is the analysis of the global Crohn's disease market by region, drug type, by distribution channel and its revenue forecast in terms of absolute dollar opportunity. This is usually overlooked while forecasting the market. However, absolute dollar opportunity is critical in assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales perspective in the global Crohn's disease market. In order to understand key market segments in terms of growth and performance in the global Crohn's disease market, Persistence Market Research has developed a market attractiveness index to help providers identify real market opportunities.

Table of Contents

1. Executive Summary

2. Crohn's Disease Market Overview

  • 2.1. Introduction
    • 2.1.1. Market Definition
    • 2.1.2. Market Taxonomy
  • 2.2. Crohn's Disease Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Value Chain
  • 2.3. Epidemiology
  • 2.4. Inflammatory Bowel Disease (IBD) Stepwise Treatment Paradigm
  • 2.5. Medications for Crohn's Disease- Current & Future Therapies

3. Global Crohn's Disease Market Forecast, 2016-2024

  • 3.1. Introduction
    • 3.1.1. Y-o-Y Growth Projections
    • 3.1.2. Absolute $ Opportunity
  • 3.2. Crohn's Disease Market Trends

4. Global Crohn's Disease Market Analysis, By Drug Type

  • 4.1. Introduction
    • 4.1.1. Basis Point Share (BPS) Analysis By Drug Type
    • 4.1.2. Y-o-Y Growth Projections By Drug Type
  • 4.2. Market Size (US$ Mn) Forecast & Absolute $ Opportunity By Drug Type
    • 4.2.1. Anti-inflammatory drugs
    • 4.2.2. Immune system suppressors
    • 4.2.3. Antibiotics
    • 4.2.4. Biologics
    • 4.2.5. Anti-diarrheal
    • 4.2.6. Pain relievers
  • 4.3. Attractiveness Analysis By Drug Type

5. Global Crohn's Disease Market Analysis, By Distribution Channel

  • 5.1. Introduction
    • 5.1.1. Basis Point Share (BPS) Analysis By Distribution Channel
    • 5.1.2. Y-o-Y Growth Projections By Distribution Channel
  • 5.2. Market Size (US$ Mn) Forecast & Absolute $ Opportunity By Distribution Channel
    • 5.2.1. Hospitals
    • 5.2.2. Retail Pharmacies
    • 5.2.3. Online Pharmacies
    • 5.2.4. Drug Stores
  • 5.3. Market Attractiveness Analysis, By Distribution Channel

6. Global Crohn's Disease Market Analysis, By Region

  • 6.1. Introduction
    • 6.1.1. Basis Point Share (BPS) Analysis By Region
    • 6.1.2. Y-o-Y Growth Projections By Region
  • 6.2. Market Size (US$ Mn) Forecast & Absolute $ Opportunity By Region
    • 6.2.1. North America
    • 6.2.2. Europe
    • 6.2.3. Asia Pacific
    • 6.2.4. Latin America
    • 6.2.5. Middle East and Africa (MEA)
  • 6.3. Market Attractiveness Analysis By Region

7. North America Crohn's Disease Market Analysis and Forecast

  • 7.1. Introduction
    • 7.1.1. Basis Point Share (BPS) Analysis By Country
    • 7.1.2. Y-o-Y Growth Projections By Country
    • 7.1.3. Market Attractiveness Analysis By Country
  • 7.2. Market Size (US$ Mn) Forecast By Country
    • 7.2.1. U.S.
    • 7.2.2. Canada
  • 7.3. Market Size (US$ Mn) Forecast By Drug type
    • 7.3.1. Anti-inflammatory drugs
    • 7.3.2. Immune system suppressors
    • 7.3.3. Antibiotics
    • 7.3.4. Biologics
    • 7.3.5. Anti-diarrheal
    • 7.3.6. Pain relievers
  • 7.4. Market Size (US$ Mn) Forecast By Distribution Channel
    • 7.4.1. Hospitals
    • 7.4.2. Retail Pharmacies
    • 7.4.3. Online Pharmacies
    • 7.4.4. Drug Stores
  • 7.5. Market Attractiveness Analysis
    • 7.5.1. By Country
    • 7.5.2. By Drug Type
    • 7.5.3. By Distribution Channel

8. Latin America Crohn's Disease Market Analysis and Forecast

  • 8.1. Introduction
    • 8.1.1. Basis Point Share (BPS) Analysis By Country
    • 8.1.2. Y-o-Y Growth Projections By Country
    • 8.1.3. Market Attractiveness Analysis By Country
  • 8.2. Market Size (US$ Mn) Forecast By Country
    • 8.2.1. Brazil
    • 8.2.2. Mexico
    • 8.2.3. Latin America
  • 8.3. Market Size (US$ Mn) Forecast By Drug type
    • 8.3.1. Anti-inflammatory drugs
    • 8.3.2. Immune system suppressors
    • 8.3.3. Antibiotics
    • 8.3.4. Biologics
    • 8.3.5. Anti-diarrheal
    • 8.3.6. Pain relievers
  • 8.4. Market Size (US$ Mn) Forecast By Distribution Channel
    • 8.4.1. Hospitals
    • 8.4.2. Retail Pharmacies
    • 8.4.3. Online Pharmacies
    • 8.4.4. Drug Stores
  • 8.5. Market Attractiveness Analysis
    • 8.5.1. By Country
    • 8.5.2. By Drug Type
    • 8.5.3. By Distribution Channel

9. Europe Crohn's Disease Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Basis Point Share (BPS) Analysis By Country
    • 9.1.2. Y-o-Y Growth Projections By Country
    • 9.1.3. Market Attractiveness Analysis By Country
  • 9.2. Market Size (US$ Mn) Forecast By Country
    • 9.2.1. Germany
    • 9.2.2. U.K.
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Russia
    • 9.2.7. Rest of Europe
  • 9.3. Market Size (US$ Mn) Forecast By Drug type
    • 9.3.1. Anti-inflammatory drugs
    • 9.3.2. Immune system suppressors
    • 9.3.3. Antibiotics
    • 9.3.4. Biologics
    • 9.3.5. Anti-diarrheal
    • 9.3.6. Pain relievers
  • 9.4. Market Size (US$ Mn) Forecast By Distribution Channel
    • 9.4.1. Hospitals
    • 9.4.2. Retail Pharmacies
    • 9.4.3. Online Pharmacies
    • 9.4.4. Drug Stores
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Country
    • 9.5.2. By Drug Type
    • 9.5.3. By Distribution Channel

10. Asia Pacific Crohn's Disease Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Basis Point Share (BPS) Analysis By Country
    • 10.1.2. Y-o-Y Growth Projections By Country
    • 10.1.3. Market Attractiveness Analysis By Country
  • 10.2. Market Size (US$ Mn) Forecast By Country
    • 10.2.1. China
    • 10.2.2. Japan
    • 10.2.3. India
    • 10.2.4. Australia and New Zealand
    • 10.2.5. ASEAN
    • 10.2.6. Rest of Asia-Pacific
  • 10.3. Market Size (US$ Mn) Forecast By Drug type
    • 10.3.1. Anti-inflammatory drugs
    • 10.3.2. Immune system suppressors
    • 10.3.3. Antibiotics
    • 10.3.4. Biologics
    • 10.3.5. Anti-diarrheal
    • 10.3.6. Pain relievers
  • 10.4. Market Size (US$ Mn) Forecast By Distribution Channel
    • 10.4.1. Hospitals
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Pharmacies
    • 10.4.4. Drug Stores
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Country
    • 10.5.2. By Drug Type
    • 10.5.3. By Distribution Channel

11. Middle East and Africa (MEA) Crohn's Disease Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Basis Point Share (BPS) Analysis By Country
    • 11.1.2. Y-o-Y Growth Projections By Country
    • 11.1.3. Market Attractiveness Analysis By Country
  • 11.2. Market Size (US$ Mn) Forecast By Country
    • 11.2.1. GCC Countries
    • 11.2.2. South Africa
    • 11.2.3. Rest of MEA
  • 11.3. Market Size (US$ Mn) Forecast By Drug type
    • 11.3.1. Anti-inflammatory drugs
    • 11.3.2. Immune system suppressors
    • 11.3.3. Antibiotics
    • 11.3.4. Biologics
    • 11.3.5. Anti-diarrheal
    • 11.3.6. Pain relievers
  • 11.4. Market Size (US$ Mn) Forecast By Distribution Channel
    • 11.4.1. Hospitals
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Online Pharmacies
    • 11.4.4. Drug Stores
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Country
    • 11.5.2. By Drug Type
    • 11.5.3. By Distribution Channel

12. Competition Landscape

  • 12.1. Competition Dashboard
  • 12.2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 12.3. Global Players
    • 12.3.1. Allergan, Inc.,
    • 12.3.2. UCB S.A.
    • 12.3.3. AbbVie Inc.
    • 12.3.4. Perrigo Company plc
    • 12.3.5. Takeda Pharmaceutical Company Limited
    • 12.3.6. Pfizer Inc.
    • 12.3.7. Johnson & Johnson Services, Inc.
    • 12.3.8. Bayer AG
    • 12.3.9. Ferring B.V.

13. Assumptions and Acronyms Used

14. Research Methodology

List of Tables:

  • Table 01: Global Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015-2024
  • Table 02: Global Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015-2024
  • Table 03: Global Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Region, 2015-2024
  • Table 04: North America Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Country, 2015-2024
  • Table 05: North America Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015-2024
  • Table 06: North America Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015-2024
  • Table 07: Latin America Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Country, 2015-2024
  • Table 08: Latin America Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015-2024
  • Table 09: Latin America Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015-2024
  • Table 10: Europe Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Country, 2015-2024
  • Table 11: Europe Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015-2024
  • Table 12: Europe Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015-2024
  • Table 13: APAC Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Country, 2015-2024
  • Table 14: APAC Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015-2024
  • Table 15: APAC Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015-2024
  • Table 16: MEA Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Country, 2015-2024
  • Table 17: MEA Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015-2024
  • Table 18: MEA Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015-2024

List of Figures

  • Figure 01: Global Crohn's Disease Market Value Share By, Region, 2015 A
  • Figure 02: Global Crohn's Disease Market Value Share By, Drug Type, 2015 A
  • Figure 03: Global Crohn's Disease Market Value Share By, Distribution Channel, 2015 A
  • Figure 04: Global Crohn's Disease Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024
  • Figure 05: Global Crohn's Disease Market Absolute $ Opportunity, 2016-2024
  • Figure 06: Global Crohn's Disease Market Share and BPS Analysis (%) By Drug Type, 2016 & 2024
  • Figure 07: Global Crohn's Disease Y-o-Y growth (%) By Drug Type, 2016-2024
  • Figure 08: Global Crohn's Disease Market Absolute $ Opportunity By Anti-inflammatory Drugs Segment,
  • Figure 09: Global Crohn's Disease Market Absolute $ Opportunity By Immune System Suppressors Segment, 2016-2024
  • Figure 10: Global Crohn's Disease Market Absolute $ Opportunity By Antibiotics Segment, 2016-2024
  • Figure 11: Global Crohn's Disease Market Absolute $ Opportunity By Biologics Segment, 2016-2024
  • Figure 12: Global Crohn's Disease Market Absolute $ Opportunity By Anti-diarrheal Segment, 2016-2024
  • Figure 13: Global Crohn's Disease Market Absolute $ Opportunity By Pain Relievers Segment, 2016-2024
  • Figure 14: Global Crohn's Disease Market Attractiveness Analysis By Drug Type, 2016-2024
  • Figure 15: Global Crohn's Disease Market Share and BPS Analysis (%) By Distribution Channel, 2016 & 2024
  • Figure 16: Global Crohn's Disease Y-o-Y growth (%) By Distribution Channel, 2016-2024
  • Figure 17: Global Crohn's Disease Market Absolute $ Opportunity By Hospital Pharmacies Segment,
  • Figure 18: Global Crohn's Disease Market Absolute $ Opportunity By Retail Pharmacies Segment, 2016-2024
  • Figure 19: Global Crohn's Disease Market Absolute $ Opportunity By Online Pharmacies Segment, 2016-2024
  • Figure 20: Global Crohn's Disease Market Absolute $ Opportunity By Drug Stores Segment, 2016-2024
  • Figure 21: Global Crohn's Disease Market Attractiveness Analysis By Distribution Channel, 2016-2024
  • Figure 22: Global Crohn's Disease Market Value (US$ Mn) and CAGR (%) By Region, 2015, 2020, and 2024
  • Figure 23: Global Crohn's Disease Market Share and BPS Analysis (%) By Region, 2016 & 2024
  • Figure 24: Global Crohn's Disease Y-o-Y growth (%) By Region, 2016-2024
  • Figure 25: North America Crohn's Disease Market Absolute $ Opportunity, 2016-2024
  • Figure 26: Latin America Crohn's Disease Market Absolute $ Opportunity, 2016-2024
  • Figure 27: Europe Crohn's Disease Market Absolute $ Opportunity, 2016-2024
  • Figure 28: APAC Crohn's Disease Market Absolute $ Opportunity, 2016-2024
  • Figure 29: Middle East and Africa Crohn's Disease Market Absolute $ Opportunity, 2016-2024
  • Figure 30: Global Crohn's Disease Market Attractiveness Analysis By Region, 2016-2024
  • Figure 31: North America Crohn's Disease Market Share Analysis (%) By Country, 2016 & 2024
  • Figure 32: North America Crohn's Disease Market Attractiveness Analysis By Country, 2016-2024
  • Figure 33: North America Crohn's Disease Y-o-Y growth (%) By Country, 2016-2024
  • Figure 34: North America Crohn's Disease Market Attractiveness Analysis By Drug Type, 2016-2024
  • Figure 35: North America Crohn's Disease Market Attractiveness Analysis By Distribution Channel, 2016-2024
  • Figure 36: Latin America Crohn's Disease Market Share Analysis (%) By Country, 2016 & 2024
  • Figure 37: Latin America Crohn's Disease Market Attractiveness Analysis By Country, 2016-2024
  • Figure 38: Latin America Crohn's Disease Y-o-Y growth (%) By Country, 2016-2024
  • Figure 39: Latin America Crohn's Disease Market Attractiveness Analysis By Drug Type, 2016-2024
  • Figure 40: Latin America Crohn's Disease Market Attractiveness Analysis By Distribution Channel, 2016-2024
  • Figure 41: Europe Crohn's Disease Market Share Analysis (%) By Country, 2016 & 2024
  • Figure 42: Europe Crohn's Disease Market Attractiveness Analysis By Country, 2016-2024
  • Figure 43: Europe Crohn's Disease Y-o-Y growth (%) By Country, 2016-2024
  • Figure 44: Europe Crohn's Disease Market Attractiveness Analysis By Drug Type, 2016-2024
  • Figure 45: Europe Crohn's Disease Market Attractiveness Analysis By Distribution Channel, 2016-2024
  • Figure 46: APAC Crohn's Disease Market Share Analysis (%) By Country, 2016 & 2024
  • Figure 47: APAC Crohn's Disease Market Attractiveness Analysis By Country, 2016-2024
  • Figure 48: APAC Crohn's Disease Y-o-Y growth (%) By Country, 2016-2024
  • Figure 49: APAC Crohn's Disease Market Attractiveness Analysis By Drug Type, 2016-2024
  • Figure 50: APAC Crohn's Disease Market Attractiveness Analysis By Distribution Channel, 2016-2024
  • Figure 51: MEA Crohn's Disease Market Share Analysis (%) By Country, 2016 & 2024
  • Figure 52: MEA Crohn's Disease Market Attractiveness Analysis By Country, 2016-2024
  • Figure 53: MEA Crohn's Disease Y-o-Y growth (%) By Country, 2016-2024
  • Figure 54: MEA Crohn's Disease Market Attractiveness Analysis By Drug Type, 2016-2024
  • Figure 55: MEA Crohn's Disease Market Attractiveness Analysis By Distribution Channel, 2016-2024
Back to Top